triaziquone has been researched along with Hemangiosarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunat, M; Dargent, M; Mayer, H; Pommatau, E | 1 |
Ehlers, G; Herbstreit, A; Kampffmeyer, U | 1 |
2 other study(ies) available for triaziquone and Hemangiosarcoma
Article | Year |
---|---|
Complete regression of metastatic tumors of the adult with antimitotic treatment.
Topics: Adolescent; Adult; Antineoplastic Agents; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Female; Follow-Up Studies; Head and Neck Neoplasms; Hemangiosarcoma; Humans; Infant; Lung Neoplasms; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Prostatic Neoplasms; Sarcoma; Teratoma; Testicular Neoplasms; Thoracic Neoplasms; Thyroid Neoplasms; Triaziquone; Uterine Neoplasms; Vinblastine | 1974 |
[Clinical, histological and cytophotometric study on primary-cutaneous metastasizing angioblastic reticulosarcoma with special reference to the effects of cytostatic agents].
Topics: Aged; Cell Differentiation; Cell Nucleus; Cytogenetics; DNA; Facial Neoplasms; Female; Hemangiosarcoma; Humans; Lymphocytes; Lymphoma, Non-Hodgkin; Neoplasm Metastasis; Prognosis; Skin Neoplasms; Triaziquone | 1971 |